A clinical trial of IMC S118AI in Type 1 diabetes mellitus
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs IMC S118AI (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 16 Jan 2025 New trial record
- 10 Jan 2025 According to Immunocore media release, Company plans to file a CTA in the second half of 2025